In a pilot study involving 36 patients with type 2 diabetes, researchers found that three months of treatment with berberine had a similar
hypoglycemic effect as the popular diabetes drug metformin.
Not exact matches
The Johns Hopkins team used a microshell made of a sugar - based polymer called cyclodextrin to protect the 3BrPA drug molecules from disintegrating early and to guard healthy tissue from the drug's toxic
effects, such
as weight loss, hypothermia and lethal
hypoglycemic shock.
Although oral
hypoglycemic medications and injected insulin are the mainstay of treatment of diabetes and are effective in controlling high blood sugars, they have side
effects such
as weight gain, swelling, and liver disease.